Latest Coronavirus Disease COVID 19 News and Research
Awareness campaign aims to alleviate unnecessary fears about calling 9-1-1 in pandemic
As new COVID-19 cases continue to rise in 22 states and strain emergency departments nationwide, the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) suggest ER visits in April were down 42% across the country compared to the same period last year.
Life Saving Drug Found for COVID-19 Patients on Ventilators
Results from Oxford University’s RECOVERY trial into existing drugs for the treatment of COVID-19 has found that dexamethasone reduced deaths by a third in ventilated coronavirus patients and by a fifth in coronavirus patients requiring oxygen. This is the first drug of its kind to be demonstrated to have a significant impact on COVID-19 mortality.
Wealthy hospital taps small craft breweries for financial aid to buy masks, gloves
As Inova Health System sought donations in March to buy personal protective equipment for its staff to treat COVID-19, Zach Mote, a police officer turned brewer, came to their aid.
Health experts link rise in Arizona COVID cases to end of stay-at-home order
With new daily coronavirus cases rising in at least two dozen states, an explosion of new infections in Arizona is stretching some hospitals and alarming public health experts who link the surge in cases to the state’s lifting of a stay-at-home order a month ago.
Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19
Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical industries, today announced that it has been selected to produce the active pharmaceutical ingredient for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of COVID-19 patients who are at high risk of deteriorating health due to age or comorbid conditions such as kidney or cardiovascular disease.
Why improved pneumonia diagnosis is needed now more than ever
News-Medical speaks to Dr. William La Via about why improved pneumonia diagnosis is vital, especially in the wake of the COVID-19 pandemic.
Many Americans face high out-of-pocket medical costs for COVID-19 hospitalizations
If past hospitalizations for pneumonia and other respiratory illnesses are any guide, many Americans could face high out-of-pocket medical costs for COVID-19 hospitalizations despite the fact that many insurers have waived their cost-sharing requirements, a study from researchers at Johns Hopkins Bloomberg School of Public Health suggests.
Study reports structure of enzyme activator for high pathogenic avian influenza
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the current pandemic of COVID-19, is the focus of many investigators seeking to find an effective vaccine or therapeutic. Among the potential targets are various protease enzymes suspected of allowing the virus to gain entry to host cells and establish a successful infection.
SARS-CoV-2 mutation reduces S1 shedding, increases infective potential
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the seventh coronavirus known to infect humans. SARS-CoV-2 emerged in the last month of 2019 in Wuhan, China, sparking off the ongoing COVID-19 pandemic. This virus enters the host cells through receptor binding and membrane fusion between the viral and host cell membrane.
Survey: Low income Vermonters have been disproportionately affected by COVID-19
High percentages of Vermonters agree with the social distancing measures put in place by the state in response to the coronavirus pandemic and have complied with them, according to a new survey.
Testing reveals 11 percent of people in Geneva infected with SARS-CoV-2
Now, a team of researchers at Geneva University Hospitals has found that less than 11 percent of the population in Geneva has contracted the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their research is published in the journal The Lancet.
Controlling SARS-CoV-2 upon resumption of the Spanish football league
The coronavirus disease (COVID-19) pandemic first emerged in Wuhan City, China, in December 2019. Since then, it has spread throughout the world, infecting more than 8 million people. Social distancing measures were imposed in most countries, isolating people in their homes, banning congregations, including schools, parties, and even sports events.
Human antibodies provide powerful protection against SARS-CoV-2 in animal tests
A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus that causes the disease, when tested in animals and human cell cultures.
Alcohol taxes have never been lower, study says
Inflation has reduced American alcohol tax rates by 70% since 1933, according to a new study from Boston University School of Public Health published in the Journal of Studies on Alcohol and Drugs.
Tracing coronavirus habitats with genomics
Now, a new study by researchers at the University of Ottawa and published on the preprint server bioRxiv in June 2020 reports the differences in genomes of viruses that are exposed to antiviral proteins vs. those that are not. This host-derived pressure on the virus to adapt may help devise newer ways to build an effective vaccine.
Inhaled steroids reduce ACE2 expression in COPD lungs
A new study by scientists at Imperial College London, University of Newcastle and Prokarium, and published on the preprint server bioRxiv* in June 2020 examines the role played by inhaled corticosteroids (ICS) in the risk of acquisition of COVID-19 infection by COPD patients.
Trio of studies identifies new human antibodies that target SARS-CoV-2 virus
A trio of papers describes several newly discovered human antibodies that target the SARS-CoV-2 virus, isolated from survivors of SARS-CoV-2 and SARS-CoV infection.
_db18a1e0805b4251a5e571357283fb21-150x125.jpg "U.S. and European SARS CoV-2 mutation enhances transmission, increases infectivity")
U.S. and European SARS CoV-2 mutation enhances transmission, increases infectivity
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is causing the COVID-19 pandemic across the world has undergone a genetic mutation in the density of functional spikes on the virus, says a new study. This has led the virus to become highly infectious and easily transmissible between humans.
Experimental drug to prevent deadly blood coagulation in patients with COVID-19
The British Heart Foundation is funding a trial for an experimental drug that could prevent the life-threatening blood clots that are seen in the lungs of the patients with COVID-19 or those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The drug named TRV027 is said to normalize the hormonal imbalance that can be seen in patients developing COVID-19, experts said.
_dc3eef4bfc1e4bdb88f6717715b35071-150x125.jpg "An inverse relationship between smoking and COVID-19")
An inverse relationship between smoking and COVID-19
Researchers at the University of Washington and Stanford University School of Medicine have reported a significant inverse relationship between current smoking and coronavirus disease 2019 (COVID-19) mortality rates across forty countries.
.png)
No hay comentarios:
Publicar un comentario